Cargando…

Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis

Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease of the bile ducts with limited therapeutic options except liver transplantation. Reliable biomarkers to predict the disease course are unavailable, and currently employed disease activity scores such as the Mayo risk score (MRS)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gauss, Annika, Sauer, Peter, Stiehl, Adolf, Rupp, Christian, Krisam, Johannes, Leopold, Yvonne, Kloeters-Plachky, Petra, Stremmel, Wolfgang, Gotthardt, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2016
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998722/ https://www.ncbi.nlm.nih.gov/pubmed/27124059 http://dx.doi.org/10.1097/MD.0000000000003510

Ejemplares similares

S100A9 is a Biliary Protein Marker of Disease Activity in Primary Sclerosing Cholangitis
por: Reinhard, Lisa, et al.
Publicado: (2012)

Microbiological Assessment of Bile and Corresponding Antibiotic Treatment: A Strobe-Compliant Observational Study of 1401 Endoscopic Retrograde Cholangiographies
por: Rupp, Christian, et al.
Publicado: (2016)

Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis
por: Rupp, Christian, et al.
Publicado: (2019)

Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease
por: Hoffmann, Peter, et al.
Publicado: (2019)

Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis
por: Rupp, Christian, et al.
Publicado: (2014)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease
por: Gauss, Annika, et al.
Publicado: (2016)

Association between serum IgG level and clinical course in primary sclerosing cholangitis
por: Hippchen, Theresa, et al.
Publicado: (2019)

Extensive Metastatic Cholangiocarcinoma Associated With IgG4-Related Sclerosing Cholangitis Misdiagnosed as Isolated IgG4-Related Sclerosing Cholangitis: A Case Report and Literature Review
por: Zhang, Yi-An, et al.
Publicado: (2015)

Primary sclerosing cholangitis with increased immunoglobulin G4 levels: A case report
por: Chen, Qing-Ling, et al.
Publicado: (2019)

Klatskin tumor diagnosed concurrently with IgG4 related sclerosing cholangitis: A case report
por: Hwang, Ha Won, et al.
Publicado: (2020)

Poor response of initial steroid therapy for IgG4-related sclerosing cholangitis with multiple organs affected
por: Liu, Wei, et al.
Publicado: (2017)

Platelet count to spleen thickness ratio is related to histologic severity of primary biliary cholangitis
por: Wang, Zhongfeng, et al.
Publicado: (2018)

A Frequent PNPLA3 Variant Is a Sex Specific Disease Modifier in PSC Patients with Bile Duct Stenosis
por: Friedrich, Kilian, et al.
Publicado: (2013)

Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis
por: Sarcognato, Samantha, et al.
Publicado: (2021)

Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases
por: Leonhardt, Silke, et al.
Publicado: (2015)

Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis
por: Fujinaga, Yukihisa, et al.
Publicado: (2021)

Combination therapy of ursodeoxycholic acid and glucocorticoid and (or) immunosuppressant in patients with primary biliary cholangitis: A meta-analysis
por: Wang, Zi-Long, et al.
Publicado: (2022)

Benefit of glucosyl Hesperidin in patients with primary biliary cholangitis: A multicenter, open-label, randomized control study
por: Moriya, Kei, et al.
Publicado: (2022)

Treatment of ursodeoxycholic acid with glucocorticoids and immunosuppressants may improve the long-term survival rate in primary biliary cholangitis patients
por: Wang, Zi-Long, et al.
Publicado: (2022)

The importance of IgG4 screening in patients diagnosed with primary sclerosing cholangitis in the past: A case rediagnosed as IgG4-SC after 10 years
por: Li, Yanni, et al.
Publicado: (2016)

A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis
por: Ma, Hong, et al.
Publicado: (2016)

A case report of motesanib-induced biliary sludge formation causing obstructive cholangitis with acute pancreatitis treated by endoscopic sphincterotomy
por: Song, Jay, et al.
Publicado: (2016)

Overlap Syndrome between Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Sundaram, Sridhar, et al.
Publicado: (2018)

Associating pancreaticostomy and biliary-irrigation for staged pancreaticoduodenectomy approach to pancreatic intraductal papillary mucinous neoplasm with recurrent cholangitis and severe jaundice: A case report
por: Dai, Chao, et al.
Publicado: (2016)

Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations
por: Nakov, Radislav, et al.
Publicado: (2020)

Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Adam, Leonie, et al.
Publicado: (2018)

Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
por: Park, Ji-Won, et al.
Publicado: (2022)

Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia: A case report
por: Zhao, Dan-Tong, et al.
Publicado: (2020)

Diagnosing Biliary Strictures: Distinguishing IgG4-Related Sclerosing Cholangitis From Cholangiocarcinoma and Primary Sclerosing Cholangitis
por: Hori, Yasuki, et al.
Publicado: (2021)

Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis
por: Malvão, Ludimilla dos Reis, et al.
Publicado: (2021)

Fecal calprotectin measurement to detect recurrence of solitary juvenile polyps: A case report
por: Kudoh, Maika, et al.
Publicado: (2023)

Overlap syndrome of primary biliary cholangitis and primary sclerosing cholangitis: two case reports
por: Yacoub, Haythem, et al.
Publicado: (2023)

Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing Cholangitis
por: Sclair, Seth N, et al.
Publicado: (2015)

Biliary endoscopy in the management of primary sclerosing cholangitis and its complications
por: Fung, Brian M., et al.
Publicado: (2019)

The Role of Microbiota in Primary Sclerosing Cholangitis and Related Biliary Malignancies
por: Özdirik, Burcin, et al.
Publicado: (2021)

Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis
por: Ryu, Dae Gon, et al.
Publicado: (2019)

Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis
por: Ludwig, Daniel R., et al.
Publicado: (2022)

A Systematic Review of Patient‐Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
por: Kim, Hannah P., et al.
Publicado: (2020)

A patient with primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis variant syndrome
por: Terziroli Beretta-Piccoli, Benedetta, et al.
Publicado: (2019)

Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis
por: Dyson, Jessica Katharine, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nobk3oltlu55qj1gk1nd4ca1n7